Top Oncology Companies
128 Oncology companies, sorted by total funding raised.
128
Companies
$12.0B
Combined Funding
1
Funded (Last 60d)
Seed
Top Stage
Indexed tracks 128 Oncology companies that have collectively raised $12.0B in documented funding. The most-funded oncology companies tracked include BeiGene and Avenzo. 1 company closed a new round in the last 60 days, with Seed being the most common funding stage.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable...
Liquid biopsy cancer screening company integrating multi-cancer early detection into routine medi...
Pathos is an AI-enabled biotechnology company focused on re-engineering drug development.
Clinical-stage oncology company developing novel CAR-T cell therapies for hematological malignanc...
Clinical-stage biopharma developing and commercializing oncology therapeutics, partnering to glob...
Provides AI and real-world oncology data solutions to life sciences companies, accelerating clini...
Cancer detection company pioneering early cancer screening using AI and biology of cancer origin.
Global oncology company focused on developing therapies to tackle the toughest challenges in canc...
Bicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional therapi...
Shanghai-based oncology biotech discovering precision and immuno-oncology therapeutics for cancer...
Commercial-stage biopharmaceutical company developing first-in-class therapeutics for hematologic...
Clinical-stage precision oncology company developing alteration-specific therapeutics for cancer ...
Clinical-stage biopharmaceutical developing novel small molecule radioligands targeting GPCRs for...
Galvanize Therapeutics is a leader in energy-based medical device technology that impacts biologi...
Clinical-stage biotech developing first-in-class logic-gated CAR-T cell therapies targeting solid...
Oncology company focused on the clinical development of novel therapies for cancer
Clinical-stage biotech engineering best-in-class CAR T-cell therapies to overcome resistance to c...
Callio Therapeutics is developing next‐generation dual‐payload antibody drug conjugates (ADCs) fo...
Black Diamond discovers and develops next-wave precision cancer medicines to treat patients with ...
Commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines th...
A precision oncology company developing highly targeted cancer therapies focused on genomic insta...
Focused on acquiring, developing and commercializing innovative anti-cancer agents in the US, Eur...
Pioneering the next generation of large molecule precision therapeutics to deliver new life-savin...
Top Investors in Oncology
Active investors ranked by total number of investments.
Frequently Asked Questions
How many Oncology companies are tracked on Indexed?
Indexed tracks 128 Oncology companies, sorted by total funding raised.
How much funding have Oncology companies raised in total?
The Oncology companies tracked by Indexed have collectively raised $12.0B in documented funding.
What are the top-funded Oncology companies?
The most-funded Oncology companies tracked include BeiGene, Avenzo, Arcellx.
Who are the top investors in Oncology?
Leading investors active in Oncology include Pfizer Ventures, Amgen, Novartis Venture Fund.
Explore More
Other Industries